Page last updated: 2024-08-23

staurosporine and inno-406

staurosporine has been researched along with inno-406 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Balistreri, G; Cattelani, L; Cerullo, V; Del Giudice, G; Federico, A; Fratello, M; Greco, D; Horvath, P; Kinaret, PAS; Kuivanen, S; Lieto, AD; Ojha, R; Pavel, A; Provenzani, R; Saarimäki, LA; Serra, A; Tasnadi, E; Vapalahti, O; Yli-Kauhaluoma, J1

Other Studies

1 other study(ies) available for staurosporine and inno-406

ArticleYear
Computationally prioritized drugs inhibit SARS-CoV-2 infection and syncytia formation.
    Briefings in bioinformatics, 2022, 01-17, Volume: 23, Issue:1

    Topics: A549 Cells; Antiviral Agents; Computational Biology; COVID-19; COVID-19 Drug Treatment; Drug Evaluation, Preclinical; Drug Repositioning; Giant Cells; Humans; Pyrimidines; SARS-CoV-2; Staurosporine

2022